May 2017
New Translational Research Facilities (TRF)
The beginning of May saw the opening of our brand new state-of-the-art Translational Research Facility dedicated to research in Obesity and Metabolic diseases. Building on our clinical research in obesity and the work of other colleagues in the Institute on insulin resistance, lipodystrophy and thyroid disease, we were able to secure funding from the Wellcome Trust to establish new Translational Research Facilities (TRF). Our vision is that with the increased space dedicated to Metabolism and with highly skilled staff, the TRF will support delivery of a portfolio of world-leading experimental medicine research. We will work to pull through basic science research in genetics and neuroscience, so that we can ultimately translate our findings into therapeutic interventions. The TRF includes space for 8 people to stay for research studies at any time and provides access to state-of-the-art equipment, which will allow us to expand the scope and reach of our clinical research, bringing in new partners and collaborators. Our aim is to recruit the best people to work in this important area and train the next generation of researchers who will drive the field forward.
